BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Large Drop in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 2,900 shares, a drop of 77.3% from the November 30th total of 12,800 shares. Based on an average daily volume of 158,000 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Stock Performance

Shares of NASDAQ:BCTXW traded down $0.03 on Thursday, hitting $0.27. 115,445 shares of the company were exchanged, compared to its average volume of 86,500. The company’s 50 day moving average price is $0.34 and its two-hundred day moving average price is $0.29. BriaCell Therapeutics has a one year low of $0.11 and a one year high of $2.60.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.